Table 3. Corneal staining of all rats in different periods.
Time |
Corneal staining |
||||||
---|---|---|---|---|---|---|---|
Group I | Group II | Group III | Group IV | Group V | Group VI | Group VII | |
72 h |
0 (n=5) |
0 (n=9) |
0 (n=9) |
0 (n=9) |
0 (n=9) |
0 (n=9) |
0 (n=14) |
4 wk |
0 (n=5)* |
1 (n=8) |
0+ (n=7) |
1 (n=9) |
1 (n=8) |
1+ (n=9) |
1 (n=13) |
8 wk |
0 (n=5)* |
1+ (n=8) |
1 (n=7) |
1+ (n=9) |
2+ (n=8) |
2+ (n=8) |
2 (n=13) |
12 wk | 0 (n=5)* | 2+ (n=7) | 2 (n=5) | 3 (n=8) | 3 (n=7) | 3 (n=6) | 3 (n=10) |
Values are expressed as medians. The “+” represents the middle of that median. The extent of corneal staining was graded according to the quantity of corneal staining: Grade 0: no staining; grade 1: up to a quarter of the cornea stained; grade 2: a quarter to half of the cornea stained; grade 3: more than half of cornea stained. The asterisk indicates that p<0.05 (Group I compared with the diabetic rats). There were no significant differences between any of the diabetic rats (Group II−VII) at any given stage. Group I: Normal; Group II: Carnosine treated (5 mg/ml); Group III: Carnosine treated (10 mg/ml); Group IV: Aspirin treated; Group V: Aminoguanidine treated (1 mg/ml); Group VI: Aminoguanidine treated (2 mg/ml); and Group VII: Untreated diabetic.